Cite
Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor.
MLA
Tröster, Alix, et al. “Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor.” Chemistry (Weinheim an Der Bergstrasse, Germany), vol. 29, no. 23, Apr. 2023, p. e202203967. EBSCOhost, https://doi.org/10.1002/chem.202203967.
APA
Tröster, A., DiPrima, M., Jores, N., Kudlinzki, D., Sreeramulu, S., Gande, S. L., Linhard, V., Ludig, D., Schug, A., Saxena, K., Reinecke, M., Heinzlmeir, S., Leisegang, M. S., Wollenhaupt, J., Lennartz, F., Weiss, M. S., Kuster, B., Tosato, G., & Schwalbe, H. (2023). Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor. Chemistry (Weinheim an Der Bergstrasse, Germany), 29(23), e202203967. https://doi.org/10.1002/chem.202203967
Chicago
Tröster, Alix, Michael DiPrima, Nathalie Jores, Denis Kudlinzki, Sridhar Sreeramulu, Santosh L Gande, Verena Linhard, et al. 2023. “Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor.” Chemistry (Weinheim an Der Bergstrasse, Germany) 29 (23): e202203967. doi:10.1002/chem.202203967.